GALECTIN THERAPE (GALT): Ownership & Insider Activity

Hedge funds and institutional managers reporting a position in GALT · Health Care. Based on the most recent 13F filing from each holder, sourced from SEC EDGAR.

Reported Holders
6
13F filers
Aggregate Value
$6.6M
Across holders
Last Price
$3.88
2026-08-24
Sector
Health Care
GICS
Quarterly fund activity0 increased5 reduced3 exited
Full exits: Hudson Bay Capital Management LP, Qube Research & Technologies Ltd, Brevan Howard Capital Management LP
Loading recent insider activity…